Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
Asthma mortality surveys report delays in seeking medical review and overuse of beta-agonist therapy as factors contributing to a fatal outcome. However, the strength of these associations is limited because many asthma deaths are unwitnessed. We undertook a secondary analysis of data from a 24-week...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Nature Publishing Group
2017
|
| Online Access: | https://eprints.nottingham.ac.uk/43274/ |